early times report
Jammu, Oct 5: The two-day Oncology Conference, hosted at the Radisson Blu, Jammu, from October 4–5, culminated in resounding success, assembling distinguished oncologists and cancer researchers from across the nation.
The conclave served as a premier academic forum to deliberate upon groundbreaking innovations, clinical challenges, and transformative advances shaping the landscape of modern cancer care.
The conference was orchestrated by Dr. Deepak Bharti, Senior Consultant, Medical Oncology, Shri Mata Vaishno Devi Narayana Hospital, Jammu. Addressing the august gathering, Dr. Bharti emphasized, “Academic congregations of this nature are fundamental in bridging clinical expertise with emerging scientific evidence, thus empowering physicians to deliver state-of-the-art oncological therapies to their patients.”
Over the course of multiple plenary and thematic sessions, domain experts engaged in erudite discussions encompassing lung, breast, gastrointestinal, head and neck, uro-oncological, hematological, and colorectal malignancies.
The symposium placed pronounced focus on revolutionary strides in immunotherapy, targeted therapy, robotic-assisted surgery, and precision oncology, heralding a new era in individualized cancer treatment.
A pivotal feature of the conference was the accentuation on Jammu’s expanding access to advanced cancer modalities. Under Dr. Bharti’s stewardship, Shri Mata Vaishno Devi Narayana Hospital has already integrated next-generation treatments such as immunotherapy within its oncology repertoire, ensuring that patients across the region avail cutting-edge care without the necessity of traveling to metropolitan centers.
The conference concluded with a resonant affirmation that platforms of such academic gravitas not only refine clinical acumen but also catalyze tangible improvements in patient outcomes — reinforcing the commitment of India’s oncological fraternity to excellence, equity, and innovation in cancer care.
|
